| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group | 
| Buprenorphine measurement | Component | True | Buprenorphine (substance) | Inferred relationship | Some | 1 | 
| Buprenorphine poisoning (disorder) | Causative agent | True | Buprenorphine (substance) | Inferred relationship | Some | 1 | 
| Accidental buprenorphine poisoning | Causative agent | False | Buprenorphine (substance) | Inferred relationship | Some |  | 
| Intentional buprenorphine poisoning | Causative agent | False | Buprenorphine (substance) | Inferred relationship | Some |  | 
| buprenorfinförgiftning, med oklar avsikt | Causative agent | False | Buprenorphine (substance) | Inferred relationship | Some | 1 | 
| Buprenorphine adverse reaction | Causative agent | True | Buprenorphine (substance) | Inferred relationship | Some | 1 | 
| Allergy to buprenorphine (finding) | Causative agent | False | Buprenorphine (substance) | Inferred relationship | Some |  | 
| Buprenorphine overdose | Causative agent | True | Buprenorphine (substance) | Inferred relationship | Some | 1 | 
| Accidental buprenorphine overdose | Causative agent | True | Buprenorphine (substance) | Inferred relationship | Some | 1 | 
| Intentional buprenorphine overdose | Causative agent | True | Buprenorphine (substance) | Inferred relationship | Some | 1 | 
| överdos av buprenorfin, med oklar avsikt | Causative agent | False | Buprenorphine (substance) | Inferred relationship | Some | 1 | 
| Product containing buprenorphine (medicinal product) | Has active ingredient | True | Buprenorphine (substance) | Inferred relationship | Some | 1 | 
| Product containing precisely buprenorphine (as buprenorphine hydrochloride) 400 microgram/1 each conventional release sublingual tablet (clinical drug) | Has active ingredient | False | Buprenorphine (substance) | Inferred relationship | Some |  | 
| Buprenorphine (as buprenorphine hydrochloride) 2 mg sublingual tablet | Has active ingredient | False | Buprenorphine (substance) | Inferred relationship | Some |  | 
| Product containing precisely buprenorphine (as buprenorphine hydrochloride) 8 milligram/1 each conventional release sublingual tablet (clinical drug) | Has active ingredient | False | Buprenorphine (substance) | Inferred relationship | Some |  | 
| Buprenorphine (as buprenorphine hydrochloride) 200 microgram sublingual tablet | Has active ingredient | False | Buprenorphine (substance) | Inferred relationship | Some |  | 
| buprenorfin 300 mikrogram/ml, injektionsvätska, lösning, ampull 1 ml | Has active ingredient | False | Buprenorphine (substance) | Inferred relationship | Some |  | 
| Buprenorphine product | Has active ingredient | False | Buprenorphine (substance) | Inferred relationship | Some |  | 
| Buprenorphine 70micrograms/hour transdermal patch | Has active ingredient | False | Buprenorphine (substance) | Inferred relationship | Some |  | 
| Buprenorphine 52.5micrograms/hour transdermal patch | Has active ingredient | False | Buprenorphine (substance) | Inferred relationship | Some |  | 
| Buprenorphine 35micrograms/hour transdermal patch | Has active ingredient | False | Buprenorphine (substance) | Inferred relationship | Some |  | 
| Buprenorphine hydrochloride + naloxone hydrochloride | Has active ingredient | False | Buprenorphine (substance) | Inferred relationship | Some |  | 
| buprenorfinhydroklorid 2 mg + naloxonhydroklorid 0,5 mg, resoriblett | Has active ingredient | False | Buprenorphine (substance) | Inferred relationship | Some |  | 
| buprenorfinhydroklorid 8 mg + naloxonhydroklorid 2 mg, resoriblett | Has active ingredient | False | Buprenorphine (substance) | Inferred relationship | Some |  | 
| Urine buprenorphine level (procedure) | Component | True | Buprenorphine (substance) | Inferred relationship | Some | 2 | 
| buprenorfin 35 mikrogram per timme, depåplåster | Has active ingredient | False | Buprenorphine (substance) | Inferred relationship | Some |  | 
| buprenorfin 52,5 mikrogram per timme, depåplåster | Has active ingredient | False | Buprenorphine (substance) | Inferred relationship | Some |  | 
| buprenorfin 70 mikrogram per timme, depåplåster | Has active ingredient | False | Buprenorphine (substance) | Inferred relationship | Some |  | 
| Serum buprenorphine level (procedure) | Component | True | Buprenorphine (substance) | Inferred relationship | Some | 2 | 
| Plasma buprenorphine level (procedure) | Component | True | Buprenorphine (substance) | Inferred relationship | Some | 2 | 
| Buprenorphine hydrochloride | Is a | False | Buprenorphine (substance) | Inferred relationship | Some |  | 
| Accidental buprenorphine poisoning | Causative agent | True | Buprenorphine (substance) | Inferred relationship | Some | 1 | 
| Intentional buprenorphine poisoning | Causative agent | True | Buprenorphine (substance) | Inferred relationship | Some | 1 | 
| Product containing buprenorphine and naloxone (medicinal product) | Has active ingredient | True | Buprenorphine (substance) | Inferred relationship | Some | 2 | 
| buprenorfin för lokalt bruk | Has active ingredient | False | Buprenorphine (substance) | Inferred relationship | Some |  | 
| läkemedel som innehåller buprenorfin, för orofaryngealt bruk | Has active ingredient | False | Buprenorphine (substance) | Inferred relationship | Some | 1 | 
| Buprenorphine-containing product in parenteral dose form | Has active ingredient | True | Buprenorphine (substance) | Inferred relationship | Some | 1 | 
| Norbuprenorphine (substance) | Is a | False | Buprenorphine (substance) | Inferred relationship | Some |  | 
| Buprenorphine 20 microgram/hour prolonged-release transdermal patch | Has active ingredient | False | Buprenorphine (substance) | Inferred relationship | Some |  | 
| Buprenorphine 10 microgram/hour prolonged-release transdermal patch | Has active ingredient | False | Buprenorphine (substance) | Inferred relationship | Some |  | 
| buprenorfin 5 mikrogram per timme, depåplåster | Has active ingredient | False | Buprenorphine (substance) | Inferred relationship | Some |  | 
| läkemedel som innehåller buprenorfin och naloxon, för orofaryngealt bruk | Has active ingredient | False | Buprenorphine (substance) | Inferred relationship | Some | 2 | 
| Allergy to buprenorphine (finding) | Causative agent | False | Buprenorphine (substance) | Inferred relationship | Some | 2 | 
| Buprenorphine hydrochloride | Is modification of (attribute) | True | Buprenorphine (substance) | Inferred relationship | Some |  | 
| Product containing precisely buprenorphine (as buprenorphine hydrochloride) 400 microgram/1 each conventional release sublingual tablet (clinical drug) | Has basis of strength substance (attribute) | True | Buprenorphine (substance) | Inferred relationship | Some | 1 | 
| Product containing precisely buprenorphine (as buprenorphine hydrochloride) 8 milligram/1 each conventional release sublingual tablet (clinical drug) | Has basis of strength substance (attribute) | True | Buprenorphine (substance) | Inferred relationship | Some | 1 | 
| Buprenorphine (as buprenorphine hydrochloride) 200 microgram sublingual tablet | Has basis of strength substance (attribute) | True | Buprenorphine (substance) | Inferred relationship | Some | 1 | 
| Buprenorphine (as buprenorphine hydrochloride) 2 mg sublingual tablet | Has basis of strength substance (attribute) | True | Buprenorphine (substance) | Inferred relationship | Some | 1 | 
| Buprenorphine-containing product in transdermal dose form | Has active ingredient | True | Buprenorphine (substance) | Inferred relationship | Some | 1 | 
| buprenorfin (som buprenorfinhydroklorid) 300 mikrogram/ml, injektionsvätska, lösning, ampull | Has basis of strength substance (attribute) | False | Buprenorphine (substance) | Inferred relationship | Some | 1 | 
| Buprenorphine 35 microgram/hour prolonged-release transdermal patch | Has basis of strength substance (attribute) | True | Buprenorphine (substance) | Inferred relationship | Some | 1 | 
| Buprenorphine 35 microgram/hour prolonged-release transdermal patch | Has precise active ingredient | True | Buprenorphine (substance) | Inferred relationship | Some | 1 | 
| Product containing precisely buprenorphine 52.5 microgram/1 hour prolonged-release transdermal patch (clinical drug) | Has precise active ingredient | True | Buprenorphine (substance) | Inferred relationship | Some | 1 | 
| Product containing precisely buprenorphine 52.5 microgram/1 hour prolonged-release transdermal patch (clinical drug) | Has basis of strength substance (attribute) | True | Buprenorphine (substance) | Inferred relationship | Some | 1 | 
| Product containing precisely buprenorphine 70 microgram/1 hour prolonged-release transdermal patch (clinical drug) | Has basis of strength substance (attribute) | True | Buprenorphine (substance) | Inferred relationship | Some | 1 | 
| Product containing precisely buprenorphine 70 microgram/1 hour prolonged-release transdermal patch (clinical drug) | Has precise active ingredient | True | Buprenorphine (substance) | Inferred relationship | Some | 1 | 
| Product containing buprenorphine in cutaneous dose form (medicinal product form) | Has active ingredient | True | Buprenorphine (substance) | Inferred relationship | Some | 1 | 
| Buprenorphine-containing product in oromucosal dose form | Has active ingredient | True | Buprenorphine (substance) | Inferred relationship | Some | 1 | 
| Buprenorphine only product | Has active ingredient | True | Buprenorphine (substance) | Inferred relationship | Some | 1 | 
| Buprenorphine and naloxone only product | Has active ingredient | True | Buprenorphine (substance) | Inferred relationship | Some | 2 | 
| Product containing only buprenorphine in parenteral dose form (medicinal product form) | Has active ingredient | True | Buprenorphine (substance) | Inferred relationship | Some | 1 | 
| Buprenorphine and naloxone only product in oromucosal dose form | Has active ingredient | True | Buprenorphine (substance) | Inferred relationship | Some | 2 | 
| Buprenorphine only product in cutaneous dose form | Has active ingredient | True | Buprenorphine (substance) | Inferred relationship | Some | 1 | 
| Buprenorphine only product in oromucosal dose form | Has active ingredient | True | Buprenorphine (substance) | Inferred relationship | Some | 1 | 
| Product containing only buprenorphine in transdermal dose form (medicinal product form) | Has active ingredient | True | Buprenorphine (substance) | Inferred relationship | Some | 1 | 
| Product containing precisely buprenorphine (as buprenorphine hydrochloride) 300 microgram/1 milliliter conventional release solution for injection (clinical drug) | Has basis of strength substance (attribute) | True | Buprenorphine (substance) | Inferred relationship | Some | 1 | 
| Allergy to buprenorphine (finding) | Causative agent | True | Buprenorphine (substance) | Inferred relationship | Some | 1 | 
| Buprenorphine 20 microgram/hour prolonged-release transdermal patch | Has basis of strength substance (attribute) | True | Buprenorphine (substance) | Inferred relationship | Some | 1 | 
| Buprenorphine 20 microgram/hour prolonged-release transdermal patch | Has precise active ingredient | True | Buprenorphine (substance) | Inferred relationship | Some | 1 | 
| Buprenorphine 10 microgram/hour prolonged-release transdermal patch | Has precise active ingredient | True | Buprenorphine (substance) | Inferred relationship | Some | 1 | 
| Buprenorphine 10 microgram/hour prolonged-release transdermal patch | Has basis of strength substance (attribute) | True | Buprenorphine (substance) | Inferred relationship | Some | 1 | 
| Buprenorphine 2 mg and naloxone hydrochloride 500 microgram sublingual tablet | Has basis of strength substance (attribute) | True | Buprenorphine (substance) | Inferred relationship | Some | 2 | 
| Buprenorphine 2 mg and naloxone hydrochloride 500 microgram sublingual tablet | Has precise active ingredient | True | Buprenorphine (substance) | Inferred relationship | Some | 2 | 
| Product containing buprenorphine and naloxone in oromucosal dose form (medicinal product form) | Has active ingredient | True | Buprenorphine (substance) | Inferred relationship | Some | 2 | 
| Buprenorphine (as buprenorphine hydrochloride) 8 mg and naloxone hydrochloride 2 mg sublingual tablet | Has basis of strength substance (attribute) | True | Buprenorphine (substance) | Inferred relationship | Some | 2 | 
| Drug addiction therapy using buprenorphine (regime/therapy) | Using substance (attribute) | True | Buprenorphine (substance) | Inferred relationship | Some | 2 | 
| Drug addiction therapy using buprenorphine and naloxone | Using substance (attribute) | True | Buprenorphine (substance) | Inferred relationship | Some | 3 | 
| buprenorfinhydroklorid 2 mg + naloxonhydroklorid 0,5 mg, resoriblett | Has active ingredient | False | Buprenorphine (substance) | Inferred relationship | Some |  | 
| buprenorfinhydroklorid 8 mg + naloxonhydroklorid 2 mg, resoriblett | Has active ingredient | False | Buprenorphine (substance) | Inferred relationship | Some |  |